Literature DB >> 34150386

A Case of Autoimmune Hemolytic Anemia Following COVID-19 Messenger Ribonucleic Acid Vaccination.

Sérgio Brito1, Nuno Ferreira1, Sofia Mateus1, Manuela Bernardo2, Beatriz Pinto3, Ana Lourenço1, Fátima Grenho1.   

Abstract

Autoimmune hemolytic anemia (AIHA) is a condition characterized by the increased destruction of red blood cells (RBCs) mediated by anti-erythrocyte autoantibodies with or without complement activation. Its clinical presentation is heterogeneous, ranging from asymptomatic to severe forms with fatal outcomes, and it can be either idiopathic or secondary to a coexisting disorder. In this report, we present a case of a patient who suffered from acute and severe AIHA after receiving the second dose of the coronavirus disease 2019 (COVID-19) messenger ribonucleic acid (mRNA) vaccine.
Copyright © 2021, Brito et al.

Entities:  

Keywords:  autoimmune hemolytic anemia; covid-19 mrna vaccine; immune-mediated hemolysis; sars-cov-2; warm autoimmune hemolytic anemia

Year:  2021        PMID： 34150386      PMCID： PMC8200779          DOI： 10.7759/cureus.15035

Source DB:  PubMed          Journal:  Cureus        ISSN： 2168-8184


  3 in total

Review 1.  New Insights in the Pathogenesis of Autoimmune Hemolytic Anemia.

Authors:  Wilma Barcellini
Journal:  Transfus Med Hemother       Date:  2015-09-07       Impact factor: 3.747

Review 2.  The Current Status of Drug Repositioning and Vaccine Developments for the COVID-19 Pandemic.

Authors:  Jung-Hyun Won; Howard Lee
Journal:  Int J Mol Sci       Date:  2020-12-21       Impact factor: 5.923

3.  COVID-19 associated with severe autoimmune hemolytic anemia.

Authors:  Jeremy Jacobs; Quentin Eichbaum
Journal:  Transfusion       Date:  2020-12-16       Impact factor: 3.337
  3 in total
  8 in total

1.  Evans syndrome in the SARS-CoV-2 era: "springing up like mushrooms".

Authors:  Bruno Fattizzo
Journal:  Blood Transfus       Date:  2021-12-01       Impact factor: 3.443

2.  Severe relapsed autoimmune hemolytic anemia after booster with mRNA-1273 COVID-19 vaccine.

Authors:  Flordeluna Z Mesina
Journal:  Hematol Transfus Cell Ther       Date:  2022-05-30

3.  Autoimmune Hemolytic Anemia After mRNA COVID Vaccine.

Authors:  Zainab Fatima; Blair R A Reece; J Suzanne Moore; Robert T Means
Journal:  J Investig Med High Impact Case Rep       Date:  2022 Jan-Dec

Review 4.  Complement Mediated Hemolytic Anemias in the COVID-19 Era: Case Series and Review of the Literature.

Authors:  Bruno Fattizzo; Raffaella Pasquale; Valentina Bellani; Wilma Barcellini; Austin G Kulasekararaj
Journal:  Front Immunol       Date:  2021-11-25       Impact factor: 7.561

5.  New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination.

Authors:  Daisuke Hidaka; Reiki Ogasawara; Shunsuke Sugimura; Fumiaki Fujii; Keisuke Kojima; Jun Nagai; Ko Ebata; Kohei Okada; Naoki Kobayashi; Masahiro Ogasawara; Masahiro Imamura; Shuichi Ota
Journal:  Int J Hematol       Date:  2021-10-23       Impact factor: 2.490

Review 6.  COVID-19 disease and autoimmune disorders: A mutual pathway.

Authors:  Mohammed Al-Beltagi; Nermin Kamal Saeed; Adel Salah Bediwy
Journal:  World J Methodol       Date:  2022-07-20

7.  Two Doses of BNT162b2 mRNA Vaccine in Patients after Hematopoietic Stem Cell Transplantation: Humoral Response and Serological Conversion Predictors.

Authors:  Maciej Majcherek; Agnieszka Matkowska-Kocjan; Donata Szymczak; Magdalena Karasek; Agnieszka Szeremet; Aleksandra Kiraga; Aneta Milanowska; Edwin Kuznik; Krzysztof Kujawa; Tomasz Wrobel; Leszek Szenborn; Anna Czyz
Journal:  Cancers (Basel)       Date:  2022-01-10       Impact factor: 6.639

8.  A Case of Autoimmune Hemolytic Anemia after the First Dose of COVID-19 mRNA-1273 Vaccine with Undetected Pernicious Anemia.

Authors:  Fnu Jaydev; Vinod Kumar; Jaikumar Khatri; Shobha Shahani; Sead Beganovic
Journal:  Case Rep Hematol       Date:  2022-01-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.